SIAPS Final Report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs. [button style=”download” link=”https://siapsprogram.org/wp-content/uploads/2018/03/SIAPS-End-of-Program-Report.pdf” color=”silver”]Download this file as a PDF[/button]
Archive Reproductive Maternal Newborn and Child Health
Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour la quantification des besoins en médicaments pour la santé reproductive, maternelle, néonatale et infantile (SRMNI). C’est ainsi que la Direction de la pharmacie et du médicament, à travers l’appui technique et financier de SIAPS, a … Read more
Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Uganda
Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government … Read more
Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Kenya
Since the report of the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government … Read more
Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Bangladesh
Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government … Read more
Challenges to Ensuring Adequate and Timely Funding for MNCH Commodities
As countries pursue the maternal, newborn, and child health (MNCH) targets established under Sustainable Development Goal 3, they will need to ensure the continuous availability of essential health commodities to prevent and treat the conditions that cause morbidity and mortality in those groups. Since the report of the United Nations Commission on Life-Saving Commodities for … Read more
Assessing Sub-National Procurement Practices of Maternal, Newborn, and Child Health Commodities in Kenya
The SIAPS Program works at both the global and country levels to improve pharmaceutical management systems that increase access to quality medicines. SIAPS has developed a methodology to assess sub-national procurement practices. This methodology was used in Kenya to assess county-level procurement practices for essential maternal, newborn, and child health (MNCH) commodities and to study … Read more
SIAPS Annual Report: Program Year 6
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
National Reproductive Health Commodities Forecasting Bangladesh 2017-2021
In 2012, SIAPS supported the Directorate General of Family Planning (DGFP) in conducting a five-year (2012-2016) forecasting exercise for reproductive health commodities and built the technical capacity of DGFP officials to manage the forecasting processes and analyze the FP2020 indicators pertinent to stock availability. SIAPS also assisted DGFP in forming the multi-stakeholder Forecasting Working Group (FWG) … Read more
Rapport de quantification des produits de la santé reproductive, maternelle, néonatale, et infantile pour la période de janvier 2016 à décembre 2020
L’accès à des médicaments appropriés est vital pour parvenir aux objectifs mondiaux en matière de santé, en particulier les produits destinés pour la santé de la femme et de l’enfant. Un élément majeur de l’accès est de garantir la disponibilité des produits. Pour cela, la quantification des besoins est indispensable. La présente activité a apporté un … Read more
